Immunexpress Revenue and Competitors
Estimated Revenue & Valuation
- Immunexpress's estimated annual revenue is currently $3.1M per year.
- Immunexpress's estimated revenue per employee is $155,000
Employee Data
- Immunexpress has 20 Employees.
- Immunexpress grew their employee count by 11% last year.
Immunexpress's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Regulatory Affairs/Quality | Reveal Email/Phone |
3 | VP Market Development and Commercial Operations | Reveal Email/Phone |
4 | VP Market Development & Commercial Operations | Reveal Email/Phone |
5 | Director Finance | Reveal Email/Phone |
6 | Sr. Director, Research & Development | Reveal Email/Phone |
7 | Director Clinical Operations | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | Chief Scientific Officer | Reveal Email/Phone |
10 | Business Development Manager | Reveal Email/Phone |
Immunexpress Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Immunexpress?
Immunexpress is a privately owned company creating revolutionary molecular diagnostics for sepsis. The company has offices in Seattle, USA and Brisbane, Australia. Immunexpress's product pipeline aims to address the overwhelming unmet clinical needs of sepsis patients, as well as clinicians, payers and healthcare systems. Unlike the traditional approach to sepsis diagnosis, SeptiCyte® quantifies the specific molecular biomarkers from a patient's immune system ('host response'). Biomarkers capture signals from a patient's immune system in response to infection. These biomarkers may hold the key to early detection of sepsis, as well as guiding the use and timing of drugs and other therapies.
keywords:N/A
N/A
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Immunexpress News
D., Chief Executive Officer of Immunexpress, added: During the COVID-19 pandemic, sepsis incidence increased. This study shows that the...
Immunexpress is a molecular diagnostic company, based out of Seattle, committed to improving outcomes for patients suspected of sepsis.
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.8M | 20 | -23% | N/A |
#2 | $1.4M | 20 | 11% | $18.5M |
#3 | $1.4M | 20 | -9% | $12.5M |
#4 | $2M | 20 | N/A | N/A |
#5 | $2M | 20 | N/A | N/A |